CHIECO BIANCHI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.222
EU - Europa 443
AS - Asia 275
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
OC - Oceania 1
Totale 4.945
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.216
CN - Cina 211
SE - Svezia 104
FI - Finlandia 98
UA - Ucraina 77
DE - Germania 71
IT - Italia 56
VN - Vietnam 46
GB - Regno Unito 20
IN - India 14
CA - Canada 6
GR - Grecia 6
IE - Irlanda 6
EU - Europa 3
FR - Francia 3
NL - Olanda 2
EG - Egitto 1
IR - Iran 1
JP - Giappone 1
NZ - Nuova Zelanda 1
SG - Singapore 1
TR - Turchia 1
Totale 4.945
Salva come PNG Salva come JPEG
Città #
Fairfield 585
Woodbridge 507
Ann Arbor 412
Chandler 410
Houston 395
Jacksonville 384
Ashburn 254
Seattle 204
Wilmington 202
Cambridge 187
Princeton 120
Beijing 65
San Diego 60
Des Moines 57
Nanjing 56
Dong Ket 46
Boardman 38
Roxbury 36
Helsinki 32
Padova 26
Medford 25
Guangzhou 21
Norwalk 14
Shenyang 12
Nanchang 11
Jiaxing 8
New York 7
Tianjin 7
Dublin 6
Indiana 6
London 6
Redwood City 6
Hebei 5
Ogden 5
Changsha 4
Borås 2
Formia 2
Hefei 2
Kharkiv 2
Kilburn 2
Los Angeles 2
Munich 2
Ningbo 2
Pune 2
Rockville 2
Rome 2
Salerno 2
Southwark 2
Taizhou 2
Tappahannock 2
Zhengzhou 2
Amsterdam 1
Buffalo 1
Capannelle 1
Chioggia 1
Cinisello Balsamo 1
Cittadella 1
Formigine 1
Giza 1
Hangzhou 1
Hanover 1
Islington 1
Jinan 1
Leawood 1
Mogliano 1
Mountain View 1
Mumbai 1
New Bedfont 1
North York 1
Nuremberg 1
Phoenix 1
Pinehaven 1
San Mateo 1
Schio 1
Serra 1
Shanghai 1
Singapore 1
Varese 1
Washington 1
Yellow Springs 1
Yenibosna 1
Totale 4.281
Salva come PNG Salva come JPEG
Nome #
Absence of the cell cycle inhibitor p27Kip1 protein predicts poor outcome in patients with stage I-III colorectal cancer. 137
Gene therapy of ovarian cancer with IFN-α-producing fibroblasts: Comparison of constitutive and inducible vectors 116
Relevance of CREB phosphorylation in the anti-apoptotic function of human T lymphotropic virus type 1 tax protein in serum-deprived murine fibroblasts 113
Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I). 106
Acquired Immunodeficiency Syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome 104
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 104
Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1. 99
HTLV-III and HTLV-I infection in populations at risk in the Veneto region of Italy. 99
PRIMARY LYMPHOMA OF THE CENTRAL-NERVOUS-SYSTEM IN 2 CHILDREN WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME 98
Mitochondria as functional targets of proteins coded by human tumor viruses 98
Chemokine receptor expression in EBV-associated lymphoproliferation in hu/SCID mice: implications for CXCL12/CXCR4 axis in lymphoma generation 98
Influence of Rex and intronic sequences on expression of spliced mRNAS produced by human T cell leukemia virus type I. 98
Interferon-α gene therapy by lentiviral vectors contrasts ovarian cancer growth through angiogenesis inhibition 98
Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes 93
Reducing the global burden of HTLV-1 infection: An agenda for research and action 93
The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs. 91
Polymorphisms in the CCR5 promoter region influence disease progression in perinatally human immunodeficiency virus type 1-infected children 91
STRUCTURAL STUDIES ON SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HIV-1 GP120 THAT BIND TO CD4 AND ENHANCE HIV-1 INFECTION 88
Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein-Barr virus-immortalized B cells 88
A search for human herpesvirus 8 (HHV-8) in HIV-1 infected mothers and their infants does not suggest vertical transmission of HHV-8 88
Analysis of the CC chemokine receptor 5 m303 mutation in infants born to HIV-1-seropositive mothers. 85
A preclinical model for the ATLL lymphoma subtype with insights into the role of microenvironment in HTLV-1-mediated lymphomagenesis 84
The P13II protein of HTLV-I: comparison with mitochondrial proteins coded by other human viruses 83
SYNTHETIC PEPTIDES FROM THE PRINCIPAL NEUTRALIZING DOMAIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENHANCE HIV-1 INFECTION THROUGH A CD4-DEPENDENT MECHANISM 82
Horizontal transmission of human immunodeficiency virus type 1 from father to child. 80
HIV load in highly purified CD8+ T cells retrieved from pulmonary and blood compartments. 78
Analysys of Tax-expressing cell lines generated from HTLV-I Tax-transgenic mice: correlation between C-MYC overexpression and neoplastic potential. 76
Spread of HTLV-1 in subjects at risk 74
p27kip1 expression is associated with tumor response to preoperative chemoradiotherapy in rectal cancer 74
Differential effect on TCR : CD3 stimulation of a 90-kD glycoprotein (gp90/Mac-2BP), a member of the scavenger receptor cysteine-rich domain protein family 73
Inflammatory polyarthropathy and bone remodeling in HTLV-I Tax-transgenic mice. 72
Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy 72
Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells. 70
Inhibition of ribonucleotide reductase by 2'-substituted deoxycytidine analogs: possible application in AIDS treatment. 69
The use of synthetic peptides in the study of HIV-1/target cell interactions 68
A case of adult T cell leukemia and lymphoma in an Italian woman showing different malignant clones in tumor mass and in blood. 68
DNA immunization of mice against SIVmac239 Gag and Env using Rev-independent expression plasmids. 66
Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-infected child 66
Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. 65
The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex. 64
Epidemiological survey of HIV infection in the Veneto region of Italy. 62
MINIMAL SEQUENCE REQUIREMENTS FOR SYNTHETIC PEPTIDES DERIVED FROM THE V3 LOOP OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO ENHANCE HIV-1 BINDING TO CELLS AND INFECTION 62
Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection. 59
Submitochondrial targeting and biochemical characterization of the p13II protein of HTLV-I 58
Synthetic Peptides Derived From the Principal Neutralizing Domain (PND) of Human Immunodeficiency Virus Type 1 (HIV-1) Enhance HIV-1 Infection 58
Functional analyses of P13II, a mitochondrial protein of human T-cell leukemia virus type-1 57
Evolution of human immunodeficiency virus type 1 in perinatally infected infants with rapid and slow progression to disease. 57
Co-receptor usage of HIV-1 primary isolates, viral burden, and CCR5 genotype in mother-to-child HIV-1 transmission 57
Synthetic peptides suitable to enhance HIV-1 virus infectivity 57
Multiple forms of tyrosine protein kinases and tyrosine protein phosphatases in lymphoid cells transformed by Abelson murine leukemia virus 56
Mitochondrial alterations induced by the p13 II protein of human T-cell leukemia virus type 1: critical role of arginine residues 55
Differential effects of angiostatin, endostatin and interferon-a1 gene transfer on in vivo growth of human breast cancer cells. 55
Peptidi Sintetici Derivati dal V3 Loop di HIV-1 Modulano l'Infezione virale 54
Cell cycle dependent metabolism of pyrimidine deoxynucleotide triphosphates in CEM cells. 54
Restriction of HIV type 1 infection in macrophages heterozygous for a deletion in the CC-chemokine receptor 5 gene. 53
Functional analysis of the p13II protein of HTLV-1 52
Functional analyses of the p13II protein of human T cell leucemia virus type I 52
HIV MONITORING OF PREGNANT-WOMEN 50
Studio dei Fattori che Determinano in Vitro l'Effetto Attivante Dose-Dipendente e Non Virus-Ristretto di Peptidi del PND 47
Synthetic peptides suitable to enhance HIV-1 virus infectivity 47
Peptidi sintetici atti a potenziare l'infettività del virus HIV-1 47
Studio dell'Interazione Gp120-CD4 Tramite l'Impiego di Peptidi di Sintesi 46
Identification of a domain in human immunodeficiency virus type 1 (HIV-1) Rev that is required for functional activity and modulates association with subnuclear compartments containing splicing factor SC35 45
Telomerase activity in cronic lymphoproliferative disorders of B cell lineage. 42
Peptidi Sintetici Appartenenti al Dominio Principale di Neutralizzazione di gp120 Modulano l'Infettività del Virus HIV-1 39
Long-term clinical outcome of AIDS-related Kaposi's sarcoma during highly active antiretroviral therapy 39
CD8(+)alphabeta(+) T cells that lack surface CD5 antigen expression are a major lymphotactin (XCL1) source in peripheral blood lymphocytes 37
Peptidi Sintetici Derivati dal Principale Dominio Neutralizzante (PND) della Gp120 dell'HIV-1 Aumentano l'Infezione Virale Attraverso un Meccanismo CD4-Dipendente 32
Nel segno della conoscenza. I docenti universitari nel Rotary Club Padova. 32
Peptidi Sintetici Appartenenti al PND di HIV-1 Aumentano l'Infettività  Virale: Ruolo degli Amminoacidi Aromatici e Basici nel Determinare le Proprietà  Biologiche e Conformazionali 29
Totale 4.959
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.567
article - articoli 14.452
book - libri 0
conference - conferenze 0
curatela - curatele 111
other - altro 0
patent - brevetti 461
selected - selezionate 0
volume - volumi 157
Totale 31.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019299 0 0 0 0 0 0 0 0 0 0 157 142
2019/20201.016 147 29 14 56 99 90 81 121 119 129 70 61
2020/2021697 41 73 19 59 12 61 12 79 107 62 99 73
2021/2022859 20 119 113 58 21 76 46 95 20 14 123 154
2022/2023771 165 89 13 113 108 130 0 51 69 4 20 9
2023/2024200 13 43 24 19 15 17 17 25 18 9 0 0
Totale 4.959